Stocks and Investing Stocks and Investing
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017
Wed, September 13, 2017
Tue, September 12, 2017
Mon, September 11, 2017
Fri, September 8, 2017

Do Kim Maintained (ALNY) at Buy with Decreased Target to $99 on, Sep 8th, 2017


Published on 2024-10-25 22:42:54 - WOPRAI, Do Kim
  Print publication without navigation


Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $105 to $99 on, Sep 8th, 2017.

Do has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $50 on, Thursday, August 10th, 2017


This is the rating of the analyst that currently disagrees with Do


  • Geoff Meacham of "Barclays" Initiated at Buy with Increased Target to $105 on, Thursday, September 7th, 2017